CUSIP: 603693102
What is CUSIP 603693102?
CUSIP 603693102 identifies INKT - MiNK Therapeutics, Inc. - Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 603693102:
As of 31 Dec 2025, 1 institutional investors reported holding 160 shares of MiNK Therapeutics, Inc. - Stock (INKT).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 160 | $1,784 | +$1,784 | $11.15 | 1 |
| 2025 Q2 | 0 | $0 | -$144,003 | $11.15 | 0 |
| 2025 Q1 | 16,667 | $144,003 | -$1,743,538 | $8.64 | 1 |
| 2024 Q4 | 808,382 | $563,868 | -$27,574 | $0.70 | 21 |
| 2024 Q3 | 846,638 | $632,308 | -$46,624 | $0.75 | 25 |
| 2024 Q2 | 898,529 | $847,784 | -$34,050 | $0.95 | 30 |
| 2024 Q1 | 936,697 | $848,062 | -$58,815 | $0.91 | 33 |
| 2023 Q4 | 990,152 | $1,053,750 | +$247,784 | $1.07 | 35 |
| 2023 Q3 | 705,125 | $785,018 | -$1,216,078 | $1.10 | 32 |
| 2023 Q2 | 1,477,425 | $3,096,334 | +$1,864,911 | $2.10 | 43 |
| 2023 Q1 | 607,606 | $1,151,328 | -$110,577 | $1.90 | 11 |
| 2022 Q4 | 653,072 | $1,702,806 | +$20,260 | $2.61 | 15 |
| 2022 Q3 | 475,610 | $1,003,000 | +$279,065 | $2.11 | 9 |
| 2022 Q2 | 355,276 | $501,000 | -$933,391 | $1.41 | 5 |
| 2022 Q1 | 779,947 | $1,756,000 | -$2,561,337 | $2.25 | 15 |
| 2021 Q4 | 1,336,901 | $5,963,000 | +$5,963,000 | $4.46 | 20 |